opioid prescriptions

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose